Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
University of California, San Diego
Eastern Cooperative Oncology Group
University of California, San Diego
University of Chicago
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Massachusetts General Hospital
Eli Lilly and Company
Sanofi
Pfizer
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company